OBJECTIVE To compare the risk of non-fatal venous thromboembolism in women receiving oral contraceptives containing drospirenone with that in women receiving oral contraceptives containing levonorgestrel. DESIGN Nested case-control and cohort study. SETTING The study was based on information from PharMetrics, a United States based company that collects information on claims paid by managed ...

background: polycystic ovary syndrome (pcos) is one of the common endocrine disorders in women of reproductive ages. it is associated with a range of disorders, such as dyslipidemia, hypertension, insulin resistance (ir), compensatory hyperinsulinemia,gestational, and type 2 diabetes, and increased risk of cardiovascular morbidity. there are different treatments available for pcos. the purpose ...

background polycystic ovarian syndrome (pcos) is the most common hormonal disorder in reproductive-age women. this syndrome is associated with many complications, so treatment of the disorder is usually warranted. objectives to evaluate the effects of a combined low-dose oral contraceptive (ld) and vitex agnus on the improvement of clinical and paraclinical parameters of pcos. methods this trip...

BACKGROUND Recent concerns have been raised about the risk of gallbladder disease associated with the use of drospirenone, a fourth-generation progestin used in oral contraceptives. We conducted a study to determine the magnitude of this risk compared with other formulations of oral contraceptives. METHODS We conducted a retrospective cohort study using the IMS LifeLink Health Plan Claims Dat...

Current low dose OCs are highly effective with an excellent safety profile and many associated health benefits No single product has been shown to be superior in efficacy, safety or tolerability There is no "one size fits all" OC; different women may require different formulations Smoking particularly after age 35 with concurrent OC use greatly increases cardiovascular and thrombotic risks Age ...

BACKGROUND Polycystic ovary syndrome (PCOS) is an endocrinopathy that affects approximately 10% of reproductive-aged women throughout their lives. Women with PCOS present with heterogeneous symptoms including ovulatory dysfunction, hyperandrogenism, and polycystic ovaries. Therefore, lifelong individualized management should be considered. Pharmacological agents commonly used to manage the symp...

To assess the effect of oral contraceptives on antinuclear antibodies (ANAs), rheumatoid factor (RF), and C-reactive protein (CRP), 3 groups of women were studied: 1) 174 women (ages 16-47) from the time of their initial uses of oral contraceptives, 2) 119 women (ages 17-39) selected from the community at random, and 3) 210 women (ages 17-47) who had been taking oral contraceptives prior to an...

BACKGROUND There is an increased risk of venous thromboembolism among women taking oral contraceptives. However, whether there is an additional risk among women with polycystic ovary syndrome (PCOS) is unknown. METHODS We developed a population-based cohort from the IMS LifeLink Health Plan Claims Database, which includes managed care organizations in the United States. Women aged 18-46 years...

background & aim: sexual health is an essential element of quality of life, affecting both physical and psychological domains. hormones used in contraceptive methods have contradictory effects on sexual function. in this study, we aimed to compare sexual function in women using combined oral contraceptives (coc) and depot medroxyprogesterone acetate (dmpa), referred to healthcare centers affili...